GMPs, QA & QC

Is FDA open to entertaining an NDI for CBD products?

Is FDA open to entertaining an NDI for CBD products?

By Stephen Daniells

The US Food and Drug Administration may be willing to sit down with a company about a possible NDI submission for full-spectrum hemp extracts, says Steve Mister, president and CEO of the Council for Responsible Nutrition (CRN).

NPA Fabricant on CBD, NDIs, FDA resuming inspections

NPA Fabricant on CBD, NDIs, FDA resuming inspections

By Stephen Daniells

FDA has stated it is making ‘substantial progress’ with CBD, and a new enforcement guidance could be very significant for the industry, said NPA’s Dr Daniel Fabricant, but he said the Agency needs to ‘get in the game’ for NDIs.

©Getty Images - z_wei

News in brief

Clorox teams with Cleveland Clinic on coronavirus guide

By Hank Schultz

Clorox, a major manufacturer of dietary supplements and household products, has partnered with the Cleveland Clinic on a guide to help businesses cope with coronavirus provisions in the workplace.

©Getty Images - ptasha

NutraIngredients-USA Awards 2020

CRN's Label Wise effort stood out among year's industry initiatives

By Hank Schultz

Making nutrition understandable for everyone is the goal of the Label Wise initiative led by the Council for Responsible Nutrition. That made it a clear choice for this year’s Editors Award for Industry Initiative of the Year.

Getty Images Zhanna Kavaliova

FDA to resume on-site domestic inspections

By Danielle Masterson

After pausing on-site surveillance inspections in March, the Food and Drug Administration plan to resume domestic inspections starting the week of July 20.

©Getty Images - Andy

Data thieves target thriving supplement industry

By Hank Schultz

Recent cyberattacks on a contract lab and a contract manufacturer lay bare the risk all data-based businesses run in a globalized world where threats can come from anywhere and can potentially be motivated by factors beyond mere financial gain.

Follow us

Products

View more

Webinars